n(1)-acetylphenylhydrazine has been researched along with Anemia, Sickle Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marikovsky, Y; Near, K; Warth, JA; Weinstein, RS | 1 |
| Lachant, NA; Tanaka, KR | 1 |
1 trial(s) available for n(1)-acetylphenylhydrazine and Anemia, Sickle Cell
| Article | Year |
|---|---|
Antioxidants in sickle cell disease: the in vitro effects of ascorbic acid.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Anemia, Sickle Cell; Antioxidants; Ascorbic Acid; Clinical Trials as Topic; Drug Evaluation; Erythrocytes; Erythrocytes, Abnormal; Heinz Bodies; Humans; In Vitro Techniques; Pentose Phosphate Pathway; Phenylhydrazines; Reticulocytes; Thalassemia; Tiopronin; Vitamin E; Vitamin E Deficiency | 1986 |
1 other study(ies) available for n(1)-acetylphenylhydrazine and Anemia, Sickle Cell
| Article | Year |
|---|---|
Sequestrocytes: a manifestation of transcellular cross-bonding of the red cell membrane in sickle cell anemia.
Topics: Adult; Anemia, Sickle Cell; Cytoskeleton; Endocytosis; Erythrocyte Count; Erythrocyte Membrane; Erythrocytes, Abnormal; Female; Glucosephosphate Dehydrogenase Deficiency; Humans; Male; Microscopy, Electron; Oxidation-Reduction; Phenylhydrazines; Vacuoles | 1989 |